Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	LIK066 2.5mg qd	19
Overall Study	STARTED	LIK066 10mg qd	19
Overall Study	STARTED	LIK066 25 mg qd	28
Overall Study	STARTED	LIK066 50 mg qd	31
Overall Study	STARTED	Placebo	29
Overall Study	COMPLETED	LIK066 2.5mg qd	19
Overall Study	COMPLETED	LIK066 10mg qd	19
Overall Study	COMPLETED	LIK066 25 mg qd	28
Overall Study	COMPLETED	LIK066 50 mg qd	30
Overall Study	COMPLETED	Placebo	29
Overall Study	NOT COMPLETED	LIK066 2.5mg qd	0
Overall Study	NOT COMPLETED	LIK066 10mg qd	0
Overall Study	NOT COMPLETED	LIK066 25 mg qd	0
Overall Study	NOT COMPLETED	LIK066 50 mg qd	1
Overall Study	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03320941/flow